Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,940 | -33,830 | -26,370 | -11,840 | -49,070 |
| Depreciation Amortization | 8,270 | 5,920 | 4,170 | 1,820 | 6,670 |
| Other Working Capital | 620 | -1,290 | -840 | -2,940 | -1,510 |
| Other Operating Activity | -10,200 | -1,370 | 2,520 | 1,210 | 5,470 |
| Operating Cash Flow | $-35,250 | $-30,570 | $-20,520 | $-11,750 | $-38,440 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,480 | -1,790 | -1,220 | -740 | -2,030 |
| Net Acquisitions | -1,970 | -2,030 | -2,000 | -2,000 | -6,970 |
| Other Investing Activity | 7,400 | 2,940 | 10,930 | 4,550 | 8,840 |
| Investing Cash Flow | $2,950 | $-880 | $7,710 | $1,810 | $-160 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 26,320 | 27,380 | 8,560 | 7,540 | 44,510 |
| Financing Cash Flow | $26,320 | $27,380 | $8,560 | $7,540 | $44,510 |
| Exchange Rate Effect | 510 | 1,050 | 260 | -40 | -840 |
| Beginning Cash Position | 11,260 | 11,260 | 11,260 | 11,260 | 6,190 |
| End Cash Position | 5,800 | 8,230 | 7,280 | 8,810 | 11,260 |
| Net Cash Flow | $-5,450 | $-3,020 | $-3,970 | $-2,450 | $5,060 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,250 | -30,570 | -20,520 | -11,750 | -38,440 |
| Free Cash Flow | -35,250 | -30,570 | -20,520 | -11,750 | -38,440 |